Related Experiment Video

Updated: Jun 11, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

[Conversion from MCI (Mild Cognitive Impairment) to Alzheimer's disease: diagnostic options and predictors]

Michaela Defranceso1, Michael Schocke, Hubert J Messner

  • 1Department für Biologische Psychologie, Karl-Franzens-Universität Graz.

Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater
|July 8, 2010
PubMed
Abstract

Insights

Mild Cognitive Impairment (MCI) significantly increases dementia risk. Advanced neuroradiologic techniques like MR-spectroscopy and FDG-PET can predict conversion to dementia, aiding early diagnosis.

Area of Science:

  • Neurology
  • Radiology
  • Geriatrics

Background:

  • Mild Cognitive Impairment (MCI) is a transitional stage between normal aging and dementia.
  • Individuals with MCI have a substantially higher risk of progressing to dementia, particularly Alzheimer's disease.
  • Early identification of MCI progression is crucial for timely intervention.

Observation:

  • Patients with MCI over 65 years old face a significantly higher risk (10-15% annually) of developing dementia compared to the general population (2% annually).
  • Neuroradiologic techniques, including Magnetic Resonance (MR)-spectroscopy, Fluorodeoxyglucose Positron Emission Tomography (FDG-PET), Diffusion-Weighted Imaging (DWI), and Voxel-Based Morphometry (VBM), show promise in predicting MCI conversion.
  • These advanced imaging methods can detect subtle structural and functional brain changes preceding clinically apparent cognitive deficits.

Findings:

  • Neuroradiologic methods like MR-spectroscopy, FDG-PET, DWI, and VBM are effective in distinguishing individuals with MCI who will progress to DAT from those who will remain stable.
  • Early detection of structural brain alterations through these imaging modalities is possible, offering a window for intervention before significant cognitive impairment manifests.

Implications:

  • Early and accurate prediction of MCI conversion to DAT using neuroradiologic techniques can facilitate timely therapeutic strategies.
  • These advanced diagnostic tools may improve patient management and potentially alter the disease trajectory for individuals at high risk.
  • Further research into these neuroradiologic markers could lead to improved diagnostic criteria and personalized treatment approaches for MCI and early dementia.

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...